ENRASENTAN
UNII QG16H8A6ZH

Substance Identification & Data

This profile provides standardized clinical and technical data for Enrasentan, uniquely identified by the FDA Unique Ingredient Identifier (UNII) QG16H8A6ZH.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 167256-08-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

QG16H8A6ZH

CAS Registry Number

167256-08-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ENRASENTAN

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C29H30O8

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

GLCKXJLCYIJMRB-UPRLRBBYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C87727

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

178103

Unique identification number in the NCBI database of chemical substances.

INN ID

7784

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

[C@H]1([C@H]([C@@H](c2cc(ccc12)OCCC)c3c(cc(cc3)OC)OCCO)C(=O)O)c4cc5OCOc5cc4

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Enrasentan. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.